Total Payments
$4,828
2024 Payments
$39.91
Companies
34
Transactions
214
Medicare Patients
5,358
Medicare Billing
$555,553

Payment Breakdown by Category

Food & Beverage$4,798 (99.4%)
Education$29.99 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,798 213 99.4%
Education $29.99 1 0.6%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $655.93 26 $0 (2021)
AstraZeneca Pharmaceuticals LP $617.12 21 $0 (2023)
Merck Sharp & Dohme Corporation $455.10 25 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $368.80 16 $0 (2021)
AbbVie Inc. $314.64 19 $0 (2021)
Novartis Pharmaceuticals Corporation $274.83 11 $0 (2021)
Mallinckrodt LLC $236.00 2 $0 (2018)
Allergan, Inc. $215.05 15 $0 (2020)
PFIZER INC. $189.56 12 $0 (2021)
Amgen Inc. $148.44 8 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $39.91 2 Dexcom, Inc. ($24.66)
2023 $14.56 1 AstraZeneca Pharmaceuticals LP ($14.56)
2021 $728.58 44 AbbVie Inc. ($246.13)
2020 $1,169 58 GlaxoSmithKline, LLC. ($323.21)
2019 $1,208 45 AstraZeneca Pharmaceuticals LP ($270.21)
2018 $995.18 45 Merck Sharp & Dohme Corporation ($245.42)
2017 $673.44 19 United Therapeutics Corporation ($125.00)

All Payment Transactions

214 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
08/13/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $24.66 General
Category: Endocrinology
06/26/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $15.25 General
Category: Obesity
01/19/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.56 General
Category: Cardiovascular and Metabolism
09/30/2021 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug) Food and Beverage In-kind items and services $16.53 General
Category: RESPIRATORY
09/17/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.92 General
Category: RESPIRATORY
09/09/2021 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $18.01 General
Category: Hepatitis B Vaccine
08/26/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.74 General
Category: NEUROSCIENCE
08/26/2021 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.55 General
Category: Cardiovascular and Metabolism
08/24/2021 Althera Pharmaceuticals LLC Roszet (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Cardiovascular
08/19/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $17.48 General
Category: NEUROSCIENCE
08/04/2021 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $17.86 General
Category: Diabetes
08/02/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.95 General
Category: NEUROSCIENCE
07/28/2021 Merck Sharp & Dohme Corporation PNEUMOVAX 23 (Biological) Food and Beverage In-kind items and services $13.21 General
Category: VACCINE
07/22/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.00 General
Category: CARDIOVASCULAR
07/21/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.32 General
Category: RESPIRATORY
07/15/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Bystolic Food and Beverage Cash or cash equivalent $21.07 General
Category: Cardiovascular
07/07/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $18.13 General
Category: NEUROSCIENCE
06/30/2021 AbbVie Inc. LINZESS (Drug) Food and Beverage In-kind items and services $18.47 General
Category: GASTROENTEROLOGY
06/25/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $13.79 General
Category: NEUROSCIENCE
06/23/2021 GlaxoSmithKline, LLC. ANORO ELLIPTA (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $15.22 General
Category: RESPIRATORY
06/18/2021 PFIZER INC. COLOGUARD DNA CAPTURE REAGENTS (Device) Food and Beverage In-kind items and services $19.93 General
Category: GASTROINTESTINAL
06/10/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $19.34 General
Category: NEUROSCIENCE
06/09/2021 Amgen Inc. Aimovig (Biological), Otezla, Repatha Food and Beverage In-kind items and services $17.91 General
Category: Neuroscience
05/27/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.20 General
Category: CARDIOVASCULAR
05/25/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $19.38 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 1,850 2,966 $951,433 $203,970
2022 12 1,677 2,536 $755,202 $157,087
2021 17 1,094 1,647 $631,111 $117,778
2020 17 737 1,370 $430,223 $76,718
Total Patients
5,358
Total Services
8,519
Medicare Billing
$555,553
Procedure Codes
59

All Medicare Procedures & Services

59 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 478 1,101 $605,550 $118,712 19.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 115 115 $73,830 $17,518 23.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 133 189 $70,875 $14,562 20.5%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 187 187 $31,416 $13,949 44.4%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 71 71 $67,947 $13,844 20.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 463 896 $18,618 $7,459 40.1%
G0008 Administration of influenza virus vaccine Office 2023 198 198 $21,384 $6,948 32.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $25,922 $3,454 13.3%
90732 Pneumococcal vaccine, 23-valent Office 2023 21 21 $6,741 $2,747 40.7%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 12 12 $9,120 $2,345 25.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 112 116 $16,820 $1,261 7.5%
G0009 Administration of pneumococcal vaccine Office 2023 20 20 $2,160 $701.80 32.5%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2023 14 14 $1,050 $468.86 44.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 388 823 $452,650 $86,163 19.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 161 242 $90,750 $19,056 21.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 107 107 $68,694 $16,695 24.3%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 174 175 $25,375 $12,286 48.4%
G0008 Administration of influenza virus vaccine Office 2022 182 183 $19,764 $6,327 32.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 31 31 $30,907 $4,518 14.6%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 19 19 $18,183 $3,808 20.9%
90732 Pneumococcal vaccine, 23-valent Office 2022 25 25 $8,025 $3,294 41.0%
36415 Insertion of needle into vein for collection of blood sample Office 2022 391 727 $14,540 $2,143 14.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 157 160 $23,200 $1,922 8.3%
G0009 Administration of pneumococcal vaccine Office 2022 23 23 $2,484 $800.58 32.2%
81002 Urinalysis, manual test Office 2022 19 21 $630.00 $72.38 11.5%

About Dr. William Tamparo, M.D

Dr. William Tamparo, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1366852212.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Tamparo, M.D has received a total of $4,828 in payments from pharmaceutical and medical device companies, with $39.91 received in 2024. These payments were reported across 214 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,798).

As a Medicare-enrolled provider, Tamparo has provided services to 5,358 Medicare beneficiaries, totaling 8,519 services with total Medicare billing of $555,553. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.

Practice Information

Products in Payments

  • TRELEGY ELLIPTA (Drug) $470.46
  • FARXIGA (Drug) $451.24
  • ENTRESTO (Drug) $274.83
  • ACTHAR (Biological) $236.00
  • SPIRIVA RESPIMAT (Drug) $222.97
  • VRAYLAR (Drug) $193.06
  • UBRELVY (Drug) $180.36
  • JANUVIA (Drug) $156.65
  • XARELTO (Drug) $126.86
  • OPSUMIT (Drug) $124.81
  • STEGLATRO (Drug) $123.47
  • BREZTRI AEROSPHERE (Drug) $123.37
  • CHANTIX (Drug) $121.68
  • PRALUENT (Biological) $118.39
  • NO_PRODUCT (Drug) $110.46
  • PNEUMOVAX 23 (Biological) $109.70
  • ANORO ELLIPTA (Drug) $102.74
  • Vascepa (Drug) $97.69
  • Aimovig (Biological) $97.26
  • Edarbi (Drug) $94.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Plainview